Article
[Differential diagnosis of myeloproliferative neoplasms. Quantitative NF-E2 immunohistochemistry for differentiating between essential thrombocythemia and primary myelofibrosis].
Der Pathologe - 1 Nov 2013
Aumann K, Frey A-V, May A M, Hauschke D, Kreutz C, Marx J P, Timmer J, Werner M, Pahl H L
Abstract excerpt
BACKGROUND: Besides essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF) the myeloproliferative neoplasms (MPN) defined by the World Health Organization (WHO) comprise the entity of unclassifiable MPNs (MPN, U). The exact differential diagnosis of the specific MPN entities can be challenging particularly at early stages of the diseases. So far, pathologists have had to rely only...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.